Credit Analysis: Pharmaron Manufacturing Services (UK) Ltd

1. Credit Opinion: CONDITIONAL

Reasoning: On a standalone basis, this entity presents severe credit concerns with negative net assets of £21.7m and sustained operating losses exceeding £13m annually. However, the company operates within the Pharmaron group structure, with explicit parent company financial support underpinning its going concern status. Any credit facility would require a formal parent company guarantee from Pharmaron UK Limited or the ultimate parent. Without such guarantee, this would be a DECLINE.

The company is technically insolvent and entirely dependent on intercompany funding to continue operations. Revenue growth of 18.7% (£7.5m to £8.9m) is encouraging but insufficient to offset the deep losses. The parent's continued capital investment commitment (£3.75m approved) signals ongoing support, but this does not mitigate standalone credit risk.

2. Financial Strength

Balance sheet position is critically weak:

• Net assets: Negative £21.7m (2024), improved from negative £25.8m (2023), but still deeply insolvent
• Shareholders' funds trajectory: Collapsed from £48,215 (2022) to negative £27.1m (2023), now showing modest improvement
• Share capital: Only £1.00 – nominal, indicating the business is funded through intercompany loans rather than equity
• Operating loss: £13.6m (2024) vs £13.7m (2023) – marginally improved but still represents losses exceeding 150% of revenue

The company's balance sheet carries no standalone capacity to absorb further losses or unexpected shocks. The entire solvency framework rests on parent company support, which the auditor has accepted as basis for going concern, but this provides no comfort to unsecured creditors or lenders without guarantees.

3. Cash Flow Assessment

Standalone cash generation is negative:

• Revenue: £8.9m (2024) – growth of £1.4m year-on-year, but gross margins are not disclosed
• Operating losses consume cash before any consideration of interest costs
• Interest and FX losses: Added £2.7m to operating losses, bringing total loss to £16.3m
• No external borrowings: The company funds entirely through the parent group, with no third-party bank debt
• Liquidity: Previously held £1.25m as security with Lloyds for BACS facilities – this has been released following a move to HSBC, suggesting either reduced banking requirements or changed facility terms

The company cannot service any external debt from its own cash flows. Any lending would effectively be relying on the parent group's willingness and ability to fund repayments. Working capital requirements are not separately disclosed but are presumably met through intercompany arrangements.

4. Monitoring Points

If a facility is approved subject to parent guarantee, the following require ongoing surveillance: